Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1052 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...

 Bohai Pharmaceuticals (OTC BB:BOPH)

Tuesday, January 12, 2010
Three Months Ended
September 30,
 
   
2009
   
2008
 
             
Sales
  $ 14,181,772     $ 11,412,018  
                 
Less: Sales Tax
    (227,168 )     (183,821 )
                 
Net sales
    13,954,604       11,228,197  
                 
Cost of sales
    (2,217,604 )     (1,854,478 )
                 
Gross profit
    11,737,000       9,373,719  
                 
Selling, general and administrative expenses
    (9,174,693 )     (6,651,539 )
                 
Interest expenses
    (148,395 )     (65,038 )
                 
Operating income
    2,413,912       2,657,142  
                 
Non-operating income
    69,072       -  
                 
Non-operating costs
    (5,269 )     (31 )
                 
Income before taxes
    2,477,715       2,657,111  
                 
Income taxes
    (555,474 )     (600,199 )
                 
Net income
  $ 1,922,241     $ 2,056,912  

________________________________________________________________________________________

Fiscal Year Ended
June 30,
 
   
2009
   
2008
 
             
Sales
  $ 50,170,014     $ 38,172,513  
                 
Less: Sales Tax
    (821,400 )     (629,489 )
Net sales
    49,348,614       37,543,024  
                 
Cost of sales
    (7,975,267 )     (5,950,680 )
                 
Gross profit
    41,373,347       31,592,344  
                 
Selling, general and administrative expenses
    (31,301,811 )     (22,601,932 )
                 
Interest expenses
    (184,404 )     (234,101 )
                 
Operating income
    9,887,132       8,756,311  
                 
Non-operating income
    49,447       8  
                 
Non-operating costs
    (36,366 )     (835 )
                 
Income before taxes
    9,900,213       8,755,484  
                 
Income taxes
    (1,906,985 )     (2,303,712 )
                 
Net income
  $ 7,993,228     $ 6,451,772

Using our post reverse merger share count of 27,912,500 yields a trailing EPS number of $0.29.